Veradigm | Gewinn Vor Steuern

Aktienkurs
4.30
Täglich Wechseln
-0.20 -4.44%
Monatlich
-9.47%
Jährlich
-19.63%
Q1 Prognose
7.75




Gewinn Vor Steuern Veränderung Datum
Ambu A/S DKK 153M 3M 2025-12
Amplifon EUR 7.16M 44.39M 2025-09
Cardinal Health USD 598M 214M 2025-09
Centene USD -6.67B 6.42B 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cigna USD 2.3B 274M 2025-09
Convatec Group USD 52M 6.3M 2024-06
CVS Health USD 1.35B 4.84B 2025-12
Diasorin EUR 50.55M 11.9M 2025-09
Elevance Health USD 215M 1.19B 2025-12
General Electric Aerospace USD 2.85B 337M 2025-12
Humana USD 527M 214M 2025-09
IQVIA Holdings USD 6.16B 5.84B 2025-09
Laboratory Of America USD 337M 32.3M 2025-09
Maximus USD 126.27M 25.8M 2025-12
McKesson USD 1.4B 344M 2025-09
Med Life RON -16.67M 23.1M 2025-06
Molina Healthcare USD 234M 142M 2025-09
Omnicell USD 9.7M 750K 2025-09
Oriola-kd EUR 2.2M 7.8M 2025-09
Owens Minor USD 35.71M 5.37M 2025-09
Quest Diagnostics USD 336M 57M 2025-09
Rede D'or Sao Luiz BRL 1.9B 699.25M 2025-09
Siemens Healthineers EUR 736M 6M 2025-06
Sonova Holding CHF 234.3M 159.4M 2025-12
Supermax Corporation Bhd MYR -143.04M 41.22M 2025-09
UnitedHealth USD 3.23B 1.16B 2025-09
Veeva Systems USD 436.85M 14.82M 2025-09
Veradigm USD 35.3M 94.8M 2022-09
Xerox USD 365M 347M 2025-09


Veradigm Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.